Commodities
Forte Biosciences Stock Surges Nearly 40%: What's Driving the Move and What Traders Should Watch
Forte Biosciences stock is rocketing nearly 40% in a single session, powered by a high-conviction clinical catalyst that has reshaped the company's near-term risk profile. Here's exactly what's moving the stock and the critical levels every trader needs on their radar.